Jim Tananbaum¸ the Face of Medicine Revolution

Not so many people have a clear understanding of healthcare growth. At the same time, most people fail to see the requirement it demands regarding capital and time. The Foresite Capital CEO Jim Tananbaum revealed that upon investing in healthcare, incredible results are possible. In the year 2011, Foresite Capital came into existence. In its establishment, the company aimed at looking into the medical projects that are not funded sufficiently, yet they give excellent results. It did a survey of various healthcare leaders such as the startup companies as well as the sprouting projects through which they continue with their mission by giving funds, information, and network. More details can be found on Crunchbase.

The world of science is not entirely explored. It is in sight for this fact that Jim Tananbaum created Foresite. He figured out that this investment would give substantial results in the medical world. Once the immediate issues such as finances and exposure are taken care of, there is indeed enough time for scientists to practice what they love. In total, Foresite has invested in 77 healthcare companies dealing with medical services, genomic sequence, biopharmaceuticals, as well as the diagnostics. The key investments that the business has addressed is Intarcia Therapeutics, Aimmune Therapeutics, 10X Genomics, and also Aerial Pharmaceuticals. Check out LinkedIn Forsite Capital for more info.

Jim Tananbaum says that his concepts become a reality not because of the amount of money invested in the venture, but by constant engagement with people who are smart and persistent in healthcare. He is a believer of teamwork. In each day, Jim Tananbaum ensures that has an hour of working out so that he can stay motivated throughout the day.

Before founding Foresite, Jim co-founded GelTex Pharmaceuticals that was responsible for bringing two drugs in the market for not more than $80 million. The company was acquired for $ 1.6 billion. Its drug Renagel at the time of acquisition had over $200 million excess of revenue run rate.

Jim Tananbaum studied at Yale University where he majored in computer science. He received his MBA from Harvard. He also has M.S. that he got from the Massachusetts Institute of Technology. From high school, his passion for integrating computer science with health care has been undying.

Visit LinkedIn to know more.

Check out his Facebook page

Leave a Reply

Your email address will not be published. Required fields are marked *